200
Participants
Start Date
May 14, 2024
Primary Completion Date
September 11, 2024
Study Completion Date
September 11, 2024
Biofortis, Unité d'Investigation Clinique, Saint-Herblain
Biofortis, Unité d'Investigation Clinique, Paris
Lead Sponsor
Collaborators (1)
BioFortis
OTHER
Lallemand Health Solutions
INDUSTRY